Clinical Trial Update: Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two Velcade-based regimens with Rituximab and chemotherapy (cyclophosphamide, doxorubicin, prednisone) or with vincristine, in newly di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Oncovin (vincristine)
• PREDNISONE (Prednisone)
• Rituxan (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-11-27